Jacob V.P. Eswarakumar

Eswarakumar Headshot picture

Krouzon Pharmaceuticals, Inc

2019

Affiliations

Yale University

Technologies

Therapeutic

Indication

Developmental Disorders

Orphan Diseases

Executive Summary

View/Download

Krouzon Pharmaceuticals, Inc. is developing a first-in-class treatment for ultra-rare orphan pediatric skeletal disorders.

Newsletter Signup

Corporate Supporters

ABCT is a Program of

An intiative of